4th Quarter - Report

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) for BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Period 4th Quarter 2020 Filed Jan 21, 2021 Signed by CYNTHIA RICE

Official filing
Firm
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Client
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Income
—
Expenses
$60,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S. 1948, H.R. 3709 -- Chronic Disease Management Act of 2019

LobbyistCovered position, as disclosed
AARON W HUNTER —
NIELS KNUTSON —
LAURA WHITTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3709 (116th), S. 1948 (116th)

Health Issues HCR

S. 1895 - Lower Health Care Costs Act H.R. 2668 - Special Diabetes Program Reauthorization Act of 2019 H.R. 2680 - Special Diabetes Program for Indians Reauthorization Act of 2019 S. 3937 - Special Diabetes Program for Indians Reauthorization Act of 2020 H.R. 2328 - Reauthorizing and Extending Americas Community Health Act (REACH Act) S. 2543 - The Prescription Drug Pricing Reduction Act of 2019 S. 2199, H.R. 4906 - Insulin Price Reduction Act S. 2004, H.R. 4010 -- Emergency Access to Insulin Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 5749 - Affordable Insulin for All Act S. 2855, H.R. 5691 - Insulin Affordability Data Collection Act H.R. 19, S. 3129 - Lower Costs, More Cures Act of 2019 Issues and legislation related to drug pricing, specifically as it relates to insulin. Issues and legislation related to a passthrough of any/all savings to beneficiaries using insulin in Medicare Part D. Issues and legislation related to providing flexibility in the split of a deductible between devices and prescription drugs. Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions. Issues related to providing (during the COVID-19 emergency period) and preserving (after the COVID-19 emergency period) telehealth/telemedicine flexibilities for individuals with type 1 diabetes. S. 4315/H.R. 6666 - COVID-19 Testing, Reaching, And Contacting Everyone Act (TRACE) Act H.R. 3630 - No Surprises Act

LobbyistCovered position, as disclosed
AARON W HUNTER —
NIELS KNUTSON —
LAURA WHITTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2855 (116th), S. 2543 (116th), H.R. 2668 (116th), H.R. 3630 (116th), H.R. 6666 (116th), H.R. 4906 (116th), S. 2004 (116th), S. 3937 (116th), H.R. 3 (116th), H.R. 5691 (116th), H.R. 2328 (116th), S. 1895 (116th), S. 4315 (116th), H.R. 2680 (116th), S. 2199 (116th), H.R. 5749 (116th), H.R. 19 (116th), S. 3129 (116th), H.R. 4010 (116th)

Budget/Appropriations BUD

H.R. 8337 - FY2021 Continuing Appropriations Resolution (P.L. 116-159) H.R. 133 - Consolidated Appropriations Act, 2021

LobbyistCovered position, as disclosed
AARON W HUNTER —
NIELS KNUTSON —
LAURA WHITTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 133 (116th), H.R. 8337 (116th)

Small Business SMB

S. 3814 - RESTART Act H.R. 6892 - To amend the CARES Act to add requirements for the Main Street Lending Program related to non-profit organizations, small businesses, minority depository institutions, and community development financial institutions, and for other purposes. Issues related to financial relief packages and nonprofit assistance in response to the COVID-19 pandemic. S. 4032/ H.R. 7324 - Universal Giving Pandemic Response Act

LobbyistCovered position, as disclosed
AARON W HUNTER —
NIELS KNUTSON —
LAURA WHITTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6892 (116th), H.R. 7324 (116th), S. 3814 (116th), S. 4032 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.